BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.

Dataset: Identification and validation of a multigene predictor of recurrence in primary laryngeal cancer.

Background: Local recurrence is the major manifestation of treatment failure in patients with operable laryngeal carcinoma. Established...

Registered by ArrayExpress Uploader
View Dataset

Background: Local recurrence is the major manifestation of treatment failure in patients with operable laryngeal carcinoma. Established clinicopathological factors cannot sufficiently predict patients that are likely to recur after treatment. Additional tools are therefore required to accurately identify patients at high risk for recurrence. Methods: Using Affymetrix U133A Genechips, we profiled fresh-frozen tumor tissues from 59 patients with operable laryngeal cancer. All patients were treated locally with surgery, with or without radiation therapy. We performed Cox regression proportional hazards modeling to identify multigene predictors of recurrence. The end-point of our analysis was disease-free survival (DFS). Gene models were directly validated in a separate, similarly treated cohort of 50 patients using Affymetrix chips. In an attempt to further validate our results, we profiled 12 selected genes of our model in formalin-fixed tumor tissues from an independent cohort of 75 patients, using quantitative real time-polymerase chain reaction (qRT-PCR). Results: We focused on genes univariately associated with DFS (p<0.05) in the training set. Among several gene models comprising different numbers of genes, a 30-gene model demonstrated optimal performance (log-rank, p<0.001). We directly applied these gene models to the validation set, after adjusting for non-biological experimental variability, and observed similar results. Specifically, median DFS, as predicted by the 30-gene model, was 34 and 80 months for high- and low-risk patients, respectively (p=0.01). Hazard Ratio (HR) for recurrence for the high-risk group was 3.87 (95% CI 1.28-11.73, p=0.017). Furthermore, unsupervised hierarchical clustering of the 75 patients, based on the qRT-PCR 12-gene profile, yielded two groups, which differed significantly in DFS (log-rank, p=0.027). HR= for recurrence was 2.26, (95% CI 1.08-4.76, p=0.031). Conclusion: We have established and validated gene models that can successfully stratify patients with laryngeal cancer, based on their risk for recurrence. Thus, patients with unfavorable prognosis, when accurately identified, could be ideal candidates for the application of more aggressive treatment modalities. Training set comprises 59 samples and validation set 50 samples

Species:
human

Samples:
109

Source:
E-GEOD-27020

PubMed:
23950933

Updated:
Dec.12, 2014

Registered:
Jun.18, 2014


Factors: (via ArrayExpress)
Sample DFS STATUS 1 = RECURRED GRADE GROUP DFS MONTHS AGE
GSM665652 1 2 validation set 94 41
GSM66565 1 1 validation set 71 74
GSM665650 1 1 validation set 13 68
GSM665649 1 2 validation set 23 82
GSM665648 1 1 validation set 24 53
GSM665647 1 1 validation set 42 70
GSM665646 1 2 validation set 9 61
GSM665645 1 1 validation set 12 74
GSM665644 1 1 validation set 80 62
GSM665643 1 1 validation set 16 63
GSM665642 0 3 validation set 20 61
GSM66564 1 1 validation set 2 55
GSM665640 1 3 validation set 15 47
GSM665639 0 2 validation set 21 60
GSM665638 0 1 validation set 21 82
GSM665637 1 2 validation set 5 69
GSM665636 0 3 validation set 18 72
GSM665635 0 2 validation set 23 57
GSM665634 0 2 validation set 18 78
GSM665633 0 2 validation set 12 63
GSM665632 0 2 validation set 24 56
GSM66563 0 2 validation set 24 73
GSM665630 0 3 validation set 27 60
GSM665629 0 2 validation set 27 76
GSM665628 1 1 validation set 22 77
GSM665627 0 2 validation set 27 64
GSM665626 0 1 validation set 28 50
GSM665625 1 1 validation set 3 69
GSM665624 1 2 validation set 20 60
GSM665623 0 1 validation set 28 48
GSM665622 0 1 validation set 30 70
GSM66562 0 1 validation set 30 53
GSM665620 0 3 validation set 20 63
GSM665619 0 1 validation set 30 56
GSM665618 0 2 validation set 31 67
GSM665617 0 1 validation set 31 67
GSM665616 1 1 validation set 8 79
GSM665615 0 2 validation set 33 60
GSM665614 1 2 validation set 6 59
GSM665613 0 1 validation set 33 53
GSM665612 0 2 validation set 34 63
GSM6656 0 1 validation set 34 69
GSM665610 0 2 validation set 35 64
GSM665609 1 2 validation set 10 72
GSM665608 0 2 validation set 36 66
GSM665607 1 2 validation set 11 67
GSM665606 1 3 validation set 34 72
GSM665605 0 1 validation set 37 67
GSM665604 0 1 validation set 38 81
GSM665603 0 1 validation set 40 54
GSM665602 0 2 training set 41 67
GSM66560 0 3 training set 42 81
GSM665600 1 2 training set 13 68
GSM665599 0 1 training set 44 41
GSM665598 0 2 training set 42 62
GSM665597 0 1 training set 43 54
GSM665596 0 1 training set 43 49
GSM665595 0 2 training set 43 55
GSM665594 0 2 training set 45 80
GSM665593 0 2 training set 44 65
GSM665592 0 1 training set 46 66
GSM66559 0 2 training set 46 67
GSM665590 0 1 training set 47 49
GSM665589 0 3 training set 48 65
GSM665588 1 2 training set 8 64
GSM665587 0 2 training set 49 68
GSM665586 0 1 training set 50 79
GSM665585 0 2 training set 51 61
GSM665584 0 2 training set 52 69
GSM665583 0 2 training set 92 60
GSM665582 1 1 training set 50 60
GSM66558 0 2 training set 52 67
GSM665580 0 1 training set 54 68
GSM665579 0 1 training set 54 59
GSM665578 1 3 training set 14 61
GSM665577 0 1 training set 1 74
GSM665576 0 2 training set 37 71
GSM665575 0 2 training set 55 60
GSM665574 0 3 training set 56 74
GSM665573 1 2 training set 20 50
GSM665572 0 3 training set 42 55
GSM66557 0 3 training set 58 69
GSM665570 1 2 training set 13 55
GSM665569 0 3 training set 57 72
GSM665568 0 3 training set 41 70
GSM665567 1 1 training set 29 46
GSM665566 0 2 training set 36 58
GSM665565 1 2 training set 6 65
GSM665564 0 1 training set 61 49
GSM665563 0 2 training set 61 48
GSM665562 0 1 training set 62 50
GSM66556 0 1 training set 43 72
GSM665560 0 2 training set 46 74
GSM665559 1 2 training set 8 62
GSM665558 0 1 training set 62 51
GSM665557 0 2 training set 43 43
GSM665556 0 2 training set 64 45
GSM665555 0 not specified training set 63 68
GSM665554 0 2 training set 65 48
GSM665553 0 2 training set 64 64
GSM665552 1 2 training set 14 88
GSM66555 0 2 training set 65 82
GSM665550 1 1 training set 16 58
GSM665549 0 1 training set 64 70
GSM665548 1 3 training set 7 58
GSM665547 0 1 training set 68 57
GSM665546 1 3 training set 8 69
GSM665545 0 not specified training set 70 60
GSM665544 0 1 training set 45 54

Tags

  • cancer
  • carcinoma
  • disease
  • laryngeal carcinoma
  • median
  • point

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2026 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use